Repeat Cytology and Human Papillomavirus Screening Strategies in Detecting Preinvasive Cervical Lesions

被引:4
|
作者
Li, Kemin [1 ]
Yin, Rutie [1 ]
机构
[1] Sichuan Univ, West China Univ Hosp 2, Dept Gynaecol, Chengdu 610064, Sichuan, Peoples R China
关键词
RANDOMIZED-TRIAL; WOMEN; NEOPLASIA; ABNORMALITIES; PERSISTENCE; INFECTION;
D O I
10.1097/MD.0000000000000435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of the present study was to determine the value of human papillomavirus (HPV) testing in screening patients with pre-invasive cervical lesions. Seven hundred thirty-four women diagnosed with atypical squamous cells of undetermined significance (ASCUS+) cervical cytology during routine screening had additional cytologic testing and HPV DNA testing within 6 months of their diagnosis, after which all women who tested positive were referred for colposcopy and biopsy. The test findings were then used to determine the screening value of HPV for diagnosing preinvasive cervical lesions. Cytology and HPV testing were compared by conventional cytology. The odds ratio (OR) of sensitivity usingASCUS+or low-grade squamous intraepithelial neoplasia (LSIL+) as a cutoff for detecting cervical intraepithelial neoplasia (CIN) II+ was, respectively, 0.78 (0.72, 0.85) and 0.82 (0.70, 0.95) (P < 0.01). The cytology for triage and conventional cytology had different sensitivities usingASCUS+ orLSIL+ as the cutoff (P < 0.01). The cytology or HPV testing and conventional cytology had a difference in sensitivity usingASCUS+, LSIL+, or high-grade squamous intraepithelial neoplasia (HSIL+) as the cutoff (P < 0.01). Cytology and HPV testing were also compared with conventional cytology. The OR of specificity usingASCUS+ orLSIL+ as the cutoff for the detection of CIN II+ was 1.97 (1.68, 2.31) and 1.10 (1.02, 1.18), respectively (P < 0.01). The cytology for triage and conventional cytology had a difference in specificity when ASCUS+ or LSIL+ was used as the cutoff (P < 0.01). Finally, the cytology or HPV testing and conventional cytology had a difference in specificity when ASCUS+, LSIL+, orHSIL+ was used as the cutoff (P < 0.01). Cytology and HPV testing and cytology for triage improved the specificity of detecting CIN II+, but this did not improve the sensitivity. Additionally, cytology or HPV testing improved the sensitivity of detecting CIN II+ but not the specificity.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan
    Sasaki, Yuri
    Iwanari, Osamu
    Arakawa, Ichiro
    Moriya, Takuya
    Mikami, Yoshiki
    Iihara, Kuniko
    Konno, Ryo
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (03) : 523 - 529
  • [2] Human papillomavirus infection (HPV) & screening strategies for cervical cancer
    Sehgal, Ashok
    Singh, Veena
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2009, 130 (03) : 234 - 240
  • [3] Predictors of Human papillomavirus (HPV) persistence after treatment of high grade cervical lesions; does cervical cytology have any prognostic value in primary HPV screening?
    Kilic, Derya
    Guler, Tolga
    Atigan, Ayhan
    Avsaroglu, Elif
    Karakaya, Yeliz Arman
    Kaleli, Ilknur
    Kaleli, Babur
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2020, 49
  • [4] Impact of Human Papillomavirus Vaccination on Cervical Cytology Screening, Colposcopy, and Treatment
    Cecilia Rodriguez, Ana
    Solomon, Diane
    Herrero, Rolando
    Hildesheim, Allan
    Gonzalez, Paula
    Wacholder, Sholom
    Porras, Carolina
    Jimenez, Silvia
    Schiffman, Mark
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (05) : 752 - 760
  • [5] Human papillomavirus test with cytology triage in organized screening for cervical cancer
    Veijalainen, Olga
    Kares, Saara
    Kujala, Paula
    Tirkkonen, Mika
    Vuento, Risto
    Kholova, Ivana
    Luukkaala, Tiina
    Osuala, Veronika
    Maenpaa, Johanna
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2016, 95 (11) : 1220 - 1227
  • [6] Application of Human Papillomavirus in Screening for Cervical Cancer and Precancerous Lesions
    Wang, Jin-Liang
    Yang, Yi-Zhuo
    Dong, Wei-Wei
    Sun, Jing
    Tao, Hai-Tao
    Li, Rui-Xin
    Hu, Yi
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 2979 - 2982
  • [7] Human Papillomavirus Genotypes in High-Grade Cervical Lesions in the United States
    Hariri, Susan
    Unger, Elizabeth R.
    Powell, Suzanne E.
    Bauer, Heidi M.
    Bennett, Nancy M.
    Bloch, Karen C.
    Niccolai, Linda M.
    Schafer, Sean
    Steinau, Martin
    Markowitz, Lauri E.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (12) : 1878 - 1886
  • [8] Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing
    Domgue, Joel Fokom
    Cunningham, Sonia A.
    Yu, Robert K.
    Shete, Sanjay
    ANNALS OF EPIDEMIOLOGY, 2019, 36 : 40 - 47
  • [9] Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
    de Kok, Inge M. C. M.
    van Rosmalen, Joost
    Dillner, Joakim
    Arbyn, Marc
    Sasieni, Peter
    Iftner, Thomas
    van Ballegooijen, Marjolein
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [10] Cervical-Cancer Screening with Human Papillomavirus and Cytologic Cotesting
    Schiffman, Mark
    Solomon, Diane
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (24) : 2324 - 2331